A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Clinical trial NCT01833494 · COMPLETED
Trial details
- NCT number
- NCT01833494
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-18
- Primary completion
- 2014-08-01
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.